What is MagBiosense?
MagBiosense is a biotechnology platform developed to commercialize a novel cardiac biomarker diagnostic technology that brings lab-quality, high-sensitivity detection to the point-of-care. The device will change how heart attacks are diagnosed in the Emergency Department by providing high-sensitivity detection of cardiac troponin I.
Company Leadership
Amos Danielli
Founder
Amos earned his degree in Electrical Engineering from Tel Aviv University in 1997, and holds both a Masters and PhD in Physical-Electronics from Tel Aviv University. Amos worked with Washington University in St. Louis and Helioris Solar Systems before joining MagBiosense.
Involved Industries
Be a Part of the Movement
We champion extraordinary entrepreneurs to create positive change – for St. Louis and for the world. Join us by applying to our Global Startup Competition, becoming a financial supporter, volunteering your time or amplifying our message.